Skip to main content
. 2020 Mar 12;7(9):1902971. doi: 10.1002/advs.201902971

Figure 2.

Figure 2

Enzyme activity of IDH1/2 wildtype and IDH1/2 mutant. IDH1/2 catalyzes the oxidative decarboxylation of isocitrate to produce α‐KG, using NADP+ as cofactor and producing NADPH and CO2 in the forward reaction. IDH1/2 mutations confer a gain‐of‐function activity that catalyzes the conversion of α‐KG into the oncometabolite R2HG in a NADPH‐dependent manner.